品牌:赛曼诺生物
起订:5mg
供应:1000mg
发货:3天内
发送询价
| C60H105N17O12 | 1256.6 | 147217-25-2 | Myristoyl-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln-OH | |
| Neurogranin (30-45) (human) | C78H134N28O19S | 1800.17 | 146554-17-8 | H-Ala-Ala-Lys-Ile-Gln-Ala-Ser-Phe-Arg-Gly-His-Met-Ala-Arg-Lys-Lys-OH |
| p60 v-src (137-157) | C111H168N30O35 | 2482.74 | 131023-24-0 | H-Val-Ala-Pro-Ser-Asp-Ser-Ile-Gln-Ala-Glu-Glu-Trp-Tyr-Phe-Gly-Lys-Ile-Thr-Arg-Arg-Glu-OH |
| Peptide ε | C83H155N39O21S | 2067.46 | 120253-69-2 | H-Glu-Arg-Met-Arg-Pro-Arg-Lys-Arg-Gln-Gly-Ser-Val-Arg-Arg-Arg-Val-OH |
| C46H79N17O11 | 1046.24 | 150626-45-2 | H-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln-OH | |
| C45H73N11O8 | 896.14 | 137168-33-3 | H-Phe-Lys-Lys-Ser-Phe-Lys-Leu-NH2 | |
| Phosphorylase Kinase β-Subunit Fragment (420-436) | C79H131N31O25S | 1947.18 | 150829-21-3 | H-Lys-Arg-Asn-Pro-Gly-Ser-Gln-Lys-Arg-Phe-Pro-Ser-Asn-Cys-Gly-Arg-Asp-OH |
| PKI-tide | C85H149N31O24 | 1989.31 | 126370-52-3 | H-Ile-Ala-Ala-Gly-Arg-Thr-Gly-Arg-Arg-Gln-Ala-Ile-His-Asp-Ile-Leu-Val-Ala-Ala-OH |
| pp60 c-src (521-533) | C62H94N16O25 | 1463.52 | 198754-34-6 | H-Thr-Ser-Thr-Glu-Pro-Gln-Tyr-Gln-Pro-Gly-Glu-Asn-Leu-OH |
| pp60 c-src (521-533) (phosphorylated) | C62H95N16O28P | 1543.5 | 149299-77-4 | H-Thr-Ser-Thr-Glu-Pro-Gln-Tyr(PO3H2)-Gln-Pro-Gly-Glu-Asn-Leu-OH |
| C56H103N17O16 | 1270.54 | 105802-84-4 | H-Pro-Leu-Ser-Arg-Thr-Leu-Ser-Val-Ala-Ala-Lys-Lys-OH | |
| Protein Kinase C (19-31) | C67H118N26O16 | 1543.84 | 121545-65-1 | H-Arg-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln-Lys-Asn-Val-OH |
| (Ser25)-Protein Kinase C (19-31) | C67H118N26O17 | 1559.84 | 136795-05-6 | H-Arg-Phe-Ala-Arg-Lys-Gly-Ser-Leu-Arg-Gln-Lys-Asn-Val-OH |
| Protein Kinase C (19-36) | C93H159N35O24 | 2151.51 | 113731-96-7 | H-Arg-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln-Lys-Asn-Val-His-Glu-Val-Lys-Asn-OH |
| Protein Kinase C (530-558) | C148H221N35O50S2 | 3354.72 | 122613-29-0 | H-Leu-Leu-Tyr-Glu-Met-Leu-Ala-Gly-Gln-Ala-Pro-Phe-Glu-Gly-Glu-Asp-Glu-Asp-Glu-Leu-Phe-Gln-Ser-Ile-Met-Glu-His-Asn-Val-NH2 |
| SAMS Peptide, (Ser77,Arg87·88)-ACC-α (74-88) (dephosphorylated) (bovine, ovine), (Ser76,Arg86·87)-ACC-α (73-87) (dephosphorylated) (E. coli, rat), (Ser77,Arg87·88)-Acetyl-CoA Carboxylase 1 (74-88) (dephosphorylated) (bovine, ovine), (Ser76,Arg86·87)-Acetyl-CoA Carboxylase 1 (73-87) (dephosphorylated) (E. coli, rat) | C74H131N29O18S2 | 1779.17 | 125911-68-4 | H-His-Met-Arg-Ser-Ala-Met-Ser-Gly-Leu-His-Leu-Val-Lys-Arg-Arg-OH |
| Syntide 2, Calmodulin-Dependent Protein Kinase Substrate | C68H122N20O18 | 1507.84 | 108334-68-5 | H-Pro-Leu-Ala-Arg-Thr-Leu-Ser-Val-Ala-Gly-Leu-Pro-Gly-Lys-Lys-OH |
| C121H164N32O27S | 2530.89 | 175799-54-9 | H-Tyr-Ser-Phe-Val-His-His-Gly-Phe-Phe-Asn-Phe-Arg-Val-Ser-Trp-Arg-Glu-Met-Leu-Ala-OH | |
| VRKRTLRRL | C51H100N22O11 | 1197.5 | 105802-82-2 | H-Val-Arg-Lys-Arg-Thr-Leu-Arg-Arg-Leu-OH |
| VEGFR-KDR/Flk-1 Antagonist Peptide, K237 | C77H99N23O18S | 1666.84 | 492444-99-2 | H-His-Thr-Met-Tyr-Tyr-His-His-Tyr-Gln-His-His-Leu-OH |
| Pseudin-2 | C122H202N36O32 | 2685.17 | H-Gly-Leu-Asn-Ala-Leu-Lys-Lys-Val-Phe-Gln-Gly-Ile-His-Glu-Ala-Ile-Lys-Leu-Ile-Asn-Asn-His-Val-Gln-OH | |
| (Lys18)-Pseudin-2 | C122H203N37O32 | 2700.18 | H-Gly-Leu-Asn-Ala-Leu-Lys-Lys-Val-Phe-Gln-Gly-Ile-His-Glu-Ala-Ile-Lys-Lys-Ile-Asn-Asn-His-Val-Gln-OH | |
| pTH-Related Protein (1-16) (human, mouse, rat), Hypercalcemia of Malignancy Factor (1-16) (human, mouse, rat) | C77H128N24O25 | 1790.01 | 126391-27-3 | H-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-OH |
| pTH-Related Protein (1-34) (human, mouse, rat), Hypercalcemia of Malignancy Factor (1-34) (human, mouse, rat), pTHrP (1-34) (human, mouse, rat) | C180H287N57O48 | 4017.61 | 112540-82-6 | H-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-OH |
| Biotinyl-pTH-Related Protein (1-34) (human, mouse, rat), Biotinyl-Hypercalcemia of Malignancy Factor (1-34) (human, mouse, rat), Biotinyl-pTHrP (1-34) (human, mouse, rat) | C190H301N59O50S | 4243.91 | Biotinyl-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-OH | |
| (Tyr0)-pTH-Related Protein (1-34) (human, mouse, rat), (Tyr0)-Hypercalcemia of Malignancy Factor (1-34) (human, mouse, rat) | C189H296N58O50 | 4180.79 | H-Tyr-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-OH | |
| pTH-Related Protein (1-34) amide (human, mouse, rat), Hypercalcemia of Malignancy Factor (1-34) amide (human, mouse, rat), pTHrP (1-34) amide (human, mouse, rat) | C180H288N58O47 | 4016.63 | 112955-31-4 | H-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-NH2 |
| (Ile5,Trp23,Tyr36)-pTH-Related Protein (1-36) (human, mouse, rat), (Ile5,Trp23,Tyr36)-Hypercalcemia of Malignancy Factor (1-36) (human, mouse, rat), (Ile5,Trp23,Tyr36)-pTHrP (1-36) (human, mouse, rat) | C196H308N58O53 | 4324.96 | 181057-31-8 | H-Ala-Val-Ser-Glu-Ile-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Trp-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Tyr-OH |
| (Tyr36)-pTH-Related Protein (1-36) (human, mouse, rat), (Tyr36)-Hypercalcemia of Malignancy Factor (1-36) (human, mouse, rat) | C194H303N59O53 | 4309.91 | 213779-11-4 | H-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Tyr-OH |
| (Tyr36)-pTH-Related Protein (1-36) amide (chicken), (Tyr36)-Hypercalcemia of Malignancy Factor (1-36) amide (chicken), (Tyr36)-pTHrp (1-36) amide (chicken) | C184H301N57O55 | 4191.76 | 152617-91-9 | H-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Ile-Phe-Leu-Gln-Asn-Leu-Ile-Glu-Gly-Val-Asn-Thr-Ala-Glu-Tyr-NH2 |
